Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-30 Purchase |
2024-05-31 4:25 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
7,861 | $6.36 | $49,996 | 44,951 (Direct) |
View |
| 2024-05-24 Purchase |
2024-05-29 4:16 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
2,500 | $6.4 | $16,000 | 65,839 (Indirect Direct) |
View |
| 2024-05-20 Purchase |
2024-05-22 07:24 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
5,000 | $6.38 | $31,900 | 86,818 (Direct) |
View |
| 2024-05-20 Purchase |
2024-05-22 07:21 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
15,000 | $6.25 | $93,750 | 66,997 (Direct) |
View |
| 2024-05-14 Purchase |
2024-05-15 07:19 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
36,300 | $5.57 | $202,191 | 266,744 (Direct) |
View |
| 2024-05-14 Purchase |
2024-05-15 07:17 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
30,000 | $5.86 | $175,800 | 272,139 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:14 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director |
21,940 | $5.49 | $120,451 | 51,551 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:11 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
5,000 | $5.53 | $27,650 | 300,762 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:08 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
30,000 | $5.55 | $166,500 | 1,167,770 (Indirect Direct) |
View |
| 2024-05-13 Purchase |
2024-05-15 07:04 am |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
30,000 | $5.47 | $164,100 | 307,533 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-15 4:37 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director |
4,000 | $7.98 | $31,920 | 64,683 (Direct) |
View |
| 2023-06-14 Sale |
2023-06-15 4:33 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
12,866 | $8.04 | $103,443 | 120,890 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-31 Option Award |
2024-06-03 4:33 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
870 | $6.46 | 52,730 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-03 4:29 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
870 | $6.46 | 67,867 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 4:21 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
7,525 | $5.08 | 242,139 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
999 | $5.63 | 51,997 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 4:32 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
999 | $5.63 | 51,860 (Direct) |
View |
| 2024-01-03 Gift |
2024-01-04 4:31 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
30,000 | $0 | 1,114,770 (Direct) |
View |
| 2023-12-19 Tax Withholding |
2023-12-20 4:42 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
5,580 | $6.05 | 249,664 (Direct) |
View |
| 2023-12-19 Tax Withholding |
2023-12-20 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
14,089 | $6.05 | 1,134,770 (Direct) |
View |
| 2023-12-19 Tax Withholding |
2023-12-20 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
2,482 | $6.05 | 274,533 (Direct) |
View |
| 2023-12-19 Tax Withholding |
2023-12-20 4:35 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
2,482 | $6.05 | 227,444 (Direct) |
View |
| 2023-12-19 Tax Withholding |
2023-12-20 4:33 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
2,482 | $6.05 | 293,539 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:47 pm |
2024-12-14 2033-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
289,000 | $0 | 493,244 (Direct) |
View |
| 2023-12-14 Tax Withholding |
2023-12-18 4:47 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer |
3,031 | $6.43 | 493,244 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:43 pm |
2024-12-14 2033-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
722,500 | $0 | 1,743,859 (Direct) |
View |
| 2023-12-14 Tax Withholding |
2023-12-18 4:43 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
13,592 | $6.43 | 1,743,859 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:40 pm |
2024-12-14 2033-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
192,500 | $0 | 435,515 (Direct) |
View |
| 2023-12-14 Tax Withholding |
2023-12-18 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer |
5,840 | $6.43 | 435,515 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:37 pm |
2024-12-14 2033-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
192,500 | $0 | 388,426 (Direct) |
View |
| 2023-12-14 Tax Withholding |
2023-12-18 4:37 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
5,475 | $6.43 | 388,426 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:34 pm |
2024-12-14 2033-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
222,500 | $0 | 454,521 (Direct) |
View |
| 2023-12-14 Tax Withholding |
2023-12-18 4:34 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer |
4,015 | $6.43 | 454,521 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-01 4:42 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
956 | $5.88 | 50,998 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-01 4:40 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
956 | $5.88 | 50,861 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 4:43 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
791 | $7.11 | 50,042 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 4:41 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
791 | $7.11 | 49,905 (Direct) |
View |
| 2023-06-13 Gift |
2023-06-15 4:50 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
25,000 | $0 | 1,034,794 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:43 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director |
55,817 | $0 | 76,162 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:42 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | LEE KENNETH B JR Director |
55,817 | $0 | 107,935 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:40 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director |
55,817 | $0 | 68,683 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:39 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
55,817 | $0 | 102,411 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:37 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director |
55,817 | $0 | 64,683 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:35 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director |
55,817 | $0 | 88,323 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:33 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
55,817 | $0 | 120,890 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:31 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | McKee Amy E Director |
55,817 | $0 | 68,683 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:29 pm |
2024-06-13 2033-06-13 |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
55,817 | $0 | 88,186 (Direct) |
View |